Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1182 |
Name of the vaccine | V710 |
Microbe | Bacteria |
Disease name | Methicillin-Resistant Staphylococcus aureus (MRSA) |
Name of bacteria | Staphylococcus aureus |
Type of vaccine | Recombinant |
Nucleic acid content | Circular DNA |
Age | 18 years and older |
Description of the vaccine | Containing S. aureus 0657nI iron surface determinate B (IsdB). |
Name of the manufacturer | Merck Sharp & Dohme Corp |
Name of the manufacturing country | Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Germany, Guatemala, Ireland, Italy, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Peru, Russian Federation, Singapore, Spain, Sweden, Taiwan, United Kingdom, United States |
Year of manufacture | 2011 |
Clinical Phase status | Clinical - Failed |
Bacterial strain | Gram-positive bacteria. |
Efficacy | 18.50% |
Vaccine formulation | NA |
Dosage | Single dose of 0.5 mL. |
Mechanism of action | IgG-antibody responses against IsdB. |
Route of administration | Intramuscular |
Indications | Prevents serious Staphylococcus aureus infections following elective cardiothoracic surgery. |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | For Bacteremia and mediastinitis. |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Single dose |
Interspecies transfer | NA |
PubMed identifier | 25483690 |
Clinical trial number | NCT00518687 |
Reference | https://www.fda.gov/media/109113/download |
Other name | NA |
Additional Links | NA |